This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
1opj
From Proteopedia
(New page: 200px<br /><applet load="1opj" size="450" color="white" frame="true" align="right" spinBox="true" caption="1opj, resolution 1.75Å" /> '''Structural basis for...) |
|||
| Line 1: | Line 1: | ||
| - | [[Image:1opj.gif|left|200px]]<br /><applet load="1opj" size=" | + | [[Image:1opj.gif|left|200px]]<br /><applet load="1opj" size="350" color="white" frame="true" align="right" spinBox="true" |
caption="1opj, resolution 1.75Å" /> | caption="1opj, resolution 1.75Å" /> | ||
'''Structural basis for the auto-inhibition of c-Abl tyrosine kinase'''<br /> | '''Structural basis for the auto-inhibition of c-Abl tyrosine kinase'''<br /> | ||
==Overview== | ==Overview== | ||
| - | c-Abl is normally regulated by an autoinhibitory mechanism, the disruption | + | c-Abl is normally regulated by an autoinhibitory mechanism, the disruption of which leads to chronic myelogenous leukemia. The details of this mechanism have been elusive because c-Abl lacks a phosphotyrosine residue that triggers the assembly of the autoinhibited form of the closely related Src kinases by internally engaging the SH2 domain. Crystal structures of c-Abl show that the N-terminal myristoyl modification of c-Abl 1b binds to the kinase domain and induces conformational changes that allow the SH2 and SH3 domains to dock onto it. Autoinhibited c-Abl forms an assembly that is strikingly similar to that of inactive Src kinases but with specific differences that explain the differential ability of the drug STI-571/Gleevec/imatinib (STI-571) to inhibit the catalytic activity of Abl, but not that of c-Src. |
==About this Structure== | ==About this Structure== | ||
| - | 1OPJ is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Mus_musculus Mus musculus] with CL, MYR and STI as [http://en.wikipedia.org/wiki/ligands ligands]. Active as [http://en.wikipedia.org/wiki/Transferase Transferase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=2.7.10.1 and 2.7.10.2 2.7.10.1 and 2.7.10.2] Full crystallographic information is available from [http:// | + | 1OPJ is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Mus_musculus Mus musculus] with <scene name='pdbligand=CL:'>CL</scene>, <scene name='pdbligand=MYR:'>MYR</scene> and <scene name='pdbligand=STI:'>STI</scene> as [http://en.wikipedia.org/wiki/ligands ligands]. Active as [http://en.wikipedia.org/wiki/Transferase Transferase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=2.7.10.1 and 2.7.10.2 2.7.10.1 and 2.7.10.2] Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1OPJ OCA]. |
==Reference== | ==Reference== | ||
| Line 22: | Line 22: | ||
[[Category: Superti-Furga, G.]] | [[Category: Superti-Furga, G.]] | ||
[[Category: Veach, D.]] | [[Category: Veach, D.]] | ||
| - | [[Category: Young, M | + | [[Category: Young, M A.]] |
[[Category: CL]] | [[Category: CL]] | ||
[[Category: MYR]] | [[Category: MYR]] | ||
| Line 28: | Line 28: | ||
[[Category: transferase]] | [[Category: transferase]] | ||
| - | ''Page seeded by [http:// | + | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 14:20:11 2008'' |
Revision as of 12:20, 21 February 2008
|
Structural basis for the auto-inhibition of c-Abl tyrosine kinase
Overview
c-Abl is normally regulated by an autoinhibitory mechanism, the disruption of which leads to chronic myelogenous leukemia. The details of this mechanism have been elusive because c-Abl lacks a phosphotyrosine residue that triggers the assembly of the autoinhibited form of the closely related Src kinases by internally engaging the SH2 domain. Crystal structures of c-Abl show that the N-terminal myristoyl modification of c-Abl 1b binds to the kinase domain and induces conformational changes that allow the SH2 and SH3 domains to dock onto it. Autoinhibited c-Abl forms an assembly that is strikingly similar to that of inactive Src kinases but with specific differences that explain the differential ability of the drug STI-571/Gleevec/imatinib (STI-571) to inhibit the catalytic activity of Abl, but not that of c-Src.
About this Structure
1OPJ is a Single protein structure of sequence from Mus musculus with , and as ligands. Active as Transferase, with EC number and 2.7.10.2 2.7.10.1 and 2.7.10.2 Full crystallographic information is available from OCA.
Reference
Structural basis for the autoinhibition of c-Abl tyrosine kinase., Nagar B, Hantschel O, Young MA, Scheffzek K, Veach D, Bornmann W, Clarkson B, Superti-Furga G, Kuriyan J, Cell. 2003 Mar 21;112(6):859-71. PMID:12654251
Page seeded by OCA on Thu Feb 21 14:20:11 2008
Categories: Mus musculus | Single protein | Transferase | Bornmann, W. | Clarkson, B. | Hantschel, O. | Kuriyan, J. | Nagar, B. | Scheffzek, K. | Superti-Furga, G. | Veach, D. | Young, M A. | CL | MYR | STI
